Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 17/20 | 1.00 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 1.00 |
| ▸ | CSNK1D | P48730 | 2/20 | 1.00 |
| ▸ | CSNK1E | P49674 | 2/20 | 1.00 |
| ▸ | ACVR1B | P36896 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | RIPK2 | O43353 | 1/20 | 1.00 |
| ▸ | PRKD3 | O94806 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | TGFBR2 | P37173 | 1/20 | 1.00 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 1.00 |
| ▸ | CSNK1A1L | Q8N752 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sb-431542 SCHEMBL29381798 | 1.00 | TGFBR1 (1.00) | TGFBR1CSNK1A1CSNK1DCSNK1EACVR1B | |
| Sb-431542 SCHEMBL310028 | 1.00 | TGFBR1 (1.00) | TGFBR1CSNK1A1CSNK1DCSNK1EACVR1B | |
| Sb-431542 SCHEMBL29432843 | 0.99 | TGFBR1 (0.98) | TGFBR1CSNK1A1CSNK1DCSNK1EACVR1B | |
| Sb-431542 SCHEMBL2681356 | 0.99 | TGFBR1 (0.98) | TGFBR1CSNK1A1CSNK1DCSNK1EACVR1B | |
| SCHEMBL29362480 | 0.94 | TGFBR1 (1.00) | TGFBR1CSNK1A1CSNK1DCSNK1EACVR1B | |
| SCHEMBL373737 | 0.94 | TGFBR1 (1.00) | TGFBR1CSNK1A1CSNK1DCSNK1EACVR1B | |
| Sb-431542 SCHEMBL155156 | 0.92 | TGFBR1 (0.85) | TGFBR1CSNK1A1CSNK1DCSNK1EACVR1B | |
| Sb-431542 SCHEMBL29353092 | 0.92 | TGFBR1 (0.85) | TGFBR1CSNK1A1CSNK1DCSNK1EACVR1B | |
| Sb-431542 SCHEMBL30033986 | 0.92 | TGFBR1 (0.85) | TGFBR1CSNK1A1CSNK1DCSNK1EACVR1B | |
| Sb-431542 SCHEMBL21046666 | 0.91 | TGFBR1 (0.84) | TGFBR1CSNK1A1CSNK1DCSNK1EACVR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12065671-B2 | Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-08-20 | — | — | US | claimed |
| EP-4347795-A1 | METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2024-04-10 | — | — | EP | claimed |
| EP-4345160-A2 | METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2024-04-03 | — | — | EP | claimed |
| EP-3347456-B1 | METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS | US HEALTH (US) | 2023-12-27 | — | — | EP | claimed |
| WO-2022251499-A1 | METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-12-01 | — | — | WO | claimed |
| WO-2022178986-A1 | METHOD AND DRUG FOR INDUCING DIFFERENTIATION OF STEM CELLS INTO MESODERM LINEAGE OR TROPHOBLAST LINEAGE | 澳门大学 | 2022-09-01 | — | — | WO | claimed |
| WO-2022093967-A1 | COMPOSITIONS AND METHODS FOR TREATING DISORDERS CHARACTERIZED WITH TGF-BETA ACTIVITY | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-05-05 | — | — | WO | claimed |
| EP-4680255-A1 | METHODS FOR PRODUCING STABLE HUMAN CHONDROCTYES AND THEIR USE FOR PROMOTING CARTILLAGE GROWTH AND REPAIR | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-4346928-B1 | BIODEGRADABLE TISSUE SCAFFOLD WITH SECONDARY MATRIX TO HOST WEAKLY ADHERENT CELLS | US HEALTH (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20250290038-A1 | METHOD FOR CONVERTING HUMAN SOMATIC CELLS INTO PROLIFERATIVE NEURAL STEM CELLS | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2025-09-18 | — | — | US | disclosed |
| US-12404489-B2 | Establishing topographic organization in three-dimensional tissue culture | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2025-09-02 | — | — | US | disclosed |
| EP-3565887-B1 | METHODS FOR GENERATING SKELETAL MUSCLE PROGENITOR CELLS | UNIV CALIFORNIA (US) | 2025-07-16 | — | — | EP | disclosed |
| US-20250136948-A1 | INDUCTION OF PLURIPOTENT CELLS | THE SCRIPPS RESEARCH INSTITUTE | 2025-05-01 | — | — | US | disclosed |
| CN-114641571-A | Treatment and prevention of WWP2 mediated diseases | 新加坡国立大学 | 2022-06-17 | — | — | CN | disclosed |
| WO-2022112809-A1 | EFFICIENT AND RAPID SPECIFICATION OF SPINAL NEURONAL SUBTYPES FROM HUMAN PLURIPOTENT STEM CELLS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2022-06-02 | — | — | WO | disclosed |
| EP-4001402-A1 | MACS-BASED PURIFICATION OF STEM CELL-DERIVED RETINAL PIGMENT EPITHELIUM | FUJIFILM Cellular Dynamics, Inc. (US) | 2022-05-25 | — | — | EP | disclosed |
| WO-2022093967-A1 | COMPOSITIONS AND METHODS FOR TREATING DISORDERS CHARACTERIZED WITH TGF-BETA ACTIVITY | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-05-05 | — | — | WO | disclosed |
| EP-3983544-A1 | TREATMENT AND PREVENTION OF DISEASE MEDIATED BY WWP2 | National University of Singapore (SG) | 2022-04-20 | — | — | EP | disclosed |
| EP-3966315-A1 | METHODS FOR THE PRODUCTION OF HEPATOCYTES | FUJIFILM Cellular Dynamics, Inc. (US) | 2022-03-16 | — | — | EP | disclosed |
| WO-2022019768-A1 | CLOSED MANUFACTURING PROCESSES FOR LARGE SCALE MANUFACTURING OF PLURIPOTENT STEM CELL DERIVED CELLS | NCARDIA B.V. (NL) | 2022-01-27 | — | — | WO | disclosed |